Navigation Links
Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
Date:4/4/2012

CHICAGO Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. The findings were presented here at the AACR Annual Meeting 2012, held March 31 - April 4.

"This is a novel immunotherapy that appears to show unusually long survival in some patients," said Lyudmila Bazhenova, M.D., associate clinical professor at the University of California-San Diego Moores Cancer Center in La Jolla, Calif.

These findings represent an updated long-term survival analysis on patients treated with belagenpumatucel-L, a cell-based allogeneic vaccine derived from four lung cancer cell lines. The open-label study included 75 patients with non-small cell lung cancer (NSCLC) two patients with stage 2 disease, 12 with stage 3A, 15 with stage 3B and 46 with stage 4. The researchers randomly assigned patients to three dose cohorts: 1.25, 2.5 or 5 107 cells/injection.

For all patients, median survival was 14.5 months, and the five-year survival rate was 20 percent. The 40 patients with stage 3B/4 cancer enrolled in the second and third dose cohorts had a median survival of 15.9 months and a one-year survival rate of 61 percent, a two-year survival rate of 41 percent and a five-year survival rate of 18 percent.

Patients with stage 3B/4 nonprogressive disease after chemotherapy had a median survival of 44.4 months; five-year survival was 50 percent, which is "unheard of for patients with NSCLC," Bazhenova said.

In contrast, patients who progressed after front-line chemotherapy had a median survival rate of 14.1 months and a 9.1 percent five-year survival rate.

Bazhenova said that although these results are intriguing, they must be confirmed in a phase III clinical trial, which is currently under way in eight countries.


'/>"/>
Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related medicine news :

1. Vaccine May Prevent TB in People With HIV
2. Vaccine Not Fail-Safe in Ongoing Mumps Outbreak
3. New strategy produces promising advance in cancer vaccines
4. Screens, Vaccine for HPV Less Beneficial in Older Women
5. New Technology Could Widen Reach of Vaccines
6. Texas-based consortium announces groundbreaking vaccine research program
7. The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies Failure to Provide Adequate Safety Research
8. Possible vaccine for mesothelioma proven safe
9. Groundbreaking research to find vaccine for hepatitis C
10. Vaccine for Asbestos-Related Cancer Looks Safe
11. CDC Awards Abt Associates Additional Contracts to Evaluate Effectiveness of H1N1 Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... ... April 01, 2020 , ... “Medical information is ... law,” says Keller Grover LLP attorney Eric A. Grover. “For that reason, ... the negligent release and disclosure of medical information can, under certain circumstances, give ...
(Date:3/28/2020)... ... March 27, 2020 , ... The construction industry is taking ... the coronavirus. Operating under the designation as an essential business as modified today ... protection projects in the downstate New York region. , While certain projects have ...
(Date:3/27/2020)... ... March 27, 2020 , ... Justin P. Kubeck, ... Docs. Dr. Kubeck has been approved every year consecutively since 2016. Dr. Kubeck ... Spinal Surgery. , Dr. Kubeck’s medical education began at Thomas Jefferson University. ...
(Date:3/22/2020)... , ... March 21, 2020 , ... In partnership with ... to honor our community’s medical professionals and first responders. The title comes from the ... of the city and its flag. , Proceeds from the sale of the ...
(Date:3/20/2020)... ... March 20, 2020 , ... CommunityMed Urgent Care , based ... The virtual waiting room lets patients present online, complete registration paperwork (including the latest ... for their turn, and get signaled that their clean exam room is ready. ...
Breaking Medicine News(10 mins):
(Date:3/22/2020)... ... March 21, 2020 , ... As the spread ... its Department of Thoracic Medicine and Surgery, and the Temple Lung Center have ... Care symptom tracking platform and triage/care coordination services. Temple is now enrolling patients, ...
(Date:3/20/2020)... ... 20, 2020 , ... Suntuity Solar ( https://suntuitysolar.com ), the ... in New Jersey, recently launched a new initiative in response to the COVID-19 ... local communities across New Jersey, Maryland and Florida. “The Suntuity Pledge” ( https://suntuitygroup.com/suntuity-cares/ ...
(Date:3/20/2020)... Md. (PRWEB) , ... March 20, 2020 , ... Users ... previous 15 days to build a crowd-sourced database of detailed location information, such as ... view of a potential interaction or exposure to the virus. The app will also ...
Breaking Medicine Technology: